AU Patent

AU2019314302A1 — Spray-dried dispersions and formulations of (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoro propan-2-yl)-1H-pyrazole-4-carboxamide

Assigned to Loxo Oncology Inc · Expires 2021-01-28 · 5y expired

What this patent protects

A spray-dried dispersions and pharmaceutical composition of (

USPTO Abstract

A spray-dried dispersions and pharmaceutical composition of (

Drugs covered by this patent

Patent Metadata

Patent number: AU2019314302A1
Jurisdiction: AU
Classification: —
Expires: 2021-01-28
Drug substance claim: No
Drug product claim: No
Assignee: Loxo Oncology Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.